GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Akari Therapeutics PLC (FRA:CLA) » Definitions » Cyclically Adjusted Book per Share

Akari Therapeutics (FRA:CLA) Cyclically Adjusted Book per Share : €23.30 (As of Mar. 2025)


View and export this data going back to 2017. Start your Free Trial

What is Akari Therapeutics Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Akari Therapeutics's adjusted book value per share for the three months ended in Mar. 2025 was €0.697. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €23.30 for the trailing ten years ended in Mar. 2025.

During the past 12 months, Akari Therapeutics's average Cyclically Adjusted Book Growth Rate was -14.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2025-05-25), Akari Therapeutics's current stock price is €0.97. Akari Therapeutics's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was €23.30. Akari Therapeutics's Cyclically Adjusted PB Ratio of today is 0.04.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Akari Therapeutics was 0.05. The lowest was 0.00. And the median was 0.00.


Akari Therapeutics Cyclically Adjusted Book per Share Historical Data

The historical data trend for Akari Therapeutics's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Akari Therapeutics Cyclically Adjusted Book per Share Chart

Akari Therapeutics Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 34.90 19.89

Akari Therapeutics Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 27.62 26.59 25.55 19.89 23.30

Competitive Comparison of Akari Therapeutics's Cyclically Adjusted Book per Share

For the Biotechnology subindustry, Akari Therapeutics's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Akari Therapeutics's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Akari Therapeutics's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Akari Therapeutics's Cyclically Adjusted PB Ratio falls into.


;
;

Akari Therapeutics Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Akari Therapeutics's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book= Book Value per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=0.697/134.9266*134.9266
=0.697

Current CPI (Mar. 2025) = 134.9266.

Akari Therapeutics Quarterly Data

Book Value per Share CPI Adj_Book
201503 85.643 99.621 115.995
201506 30.964 100.684 41.495
201509 62.523 100.392 84.031
201512 75.934 99.792 102.668
201603 70.677 100.470 94.916
201606 61.324 101.688 81.369
201609 62.083 101.861 82.236
201612 54.890 101.863 72.707
201703 35.552 102.862 46.634
201706 34.530 103.349 45.080
201709 18.577 104.136 24.070
201712 18.997 104.011 24.644
201803 17.351 105.290 22.235
201806 9.679 106.317 12.284
201809 6.838 106.507 8.663
201812 3.462 105.998 4.407
201903 1.362 107.251 1.713
201906 -1.472 108.070 -1.838
201909 2.810 108.329 3.500
201912 0.006 108.420 0.007
202003 1.144 108.902 1.417
202006 1.751 108.767 2.172
202009 2.436 109.815 2.993
202012 4.009 109.897 4.922
202103 1.719 111.754 2.075
202106 0.665 114.631 0.783
202109 4.058 115.734 4.731
202112 2.066 117.630 2.370
202203 4.263 121.301 4.742
202206 2.655 125.017 2.865
202212 0.454 125.222 0.489
202303 0.000 127.348 0.000
202306 0.507 128.729 0.531
202309 0.000 129.860 0.000
202312 -0.032 129.419 -0.033
202403 -0.409 131.776 -0.419
202406 -0.283 132.554 -0.288
202409 -0.497 133.029 -0.504
202412 0.798 133.157 0.809
202503 0.697 134.927 0.697

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Akari Therapeutics  (FRA:CLA) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Akari Therapeutics's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=0.97/23.30
=0.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Akari Therapeutics was 0.05. The lowest was 0.00. And the median was 0.00.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Akari Therapeutics Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Akari Therapeutics's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Akari Therapeutics Business Description

Industry
Traded in Other Exchanges
Address
22 Boston Wharf Road, Boston, MA, USA, 02210
Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing therapies for autoimmune and inflammatory diseases involving the complement component 5 (C5) and leukotriene B4 (LTB4) pathways. The company's pipelines include HSCT-TMA and Geographic Atrophy (GA).